Cleaning Validation in the  Pharmaceutical Industry

Cleaning validation has been the most debated compliance topic of the year 2018. Cleaning validation is a critical aspect of GMP and quality control, and is under constant scrutiny by the FDA and other regulatory authorities. cGMPs include the prevention of possible contamination and cross-contamination of APIs and Finished products.

An example from 1988  of major cross contamination was traceable  back to inadequate cleaning and cleaning validation.


A more recent example,story_1


Cleaning is defined as the removal of residues and contaminants from process equipment to a scientifically acceptable level, such that the same equipment can be safely used for subsequent product manufacture.  The residues and contaminants can be from

  • Cross-contamination from previously manufactured products in the equipment    
  • The cleaning procedure (detergents / sanitizers) or degradation products resulting from the cleaning process 
  • Microbiological sources
  • Precursors of the drug substance.  By-products and/or degradation products of the drug substance

Cleaning Validation

Pharmaceutical manufacturers must validate their cleaning process to ensure compliance with cGMP regulations. Formally, “Cleaning validation is documented evidence that an approved cleaning procedure will reproducibly remove the previous product or cleaning agents used in the equipment below the scientifically set maximum  allowable carryover level”.  It is thus, a quality control process for determining the effectiveness of a cleaning process for a specific cleaning event. (Source: PIC/S Guide to GMP for Medicinal Products; Annex 15 Qualification & Validation)  


The industry is slowly adopting HBELs (Health Based Exposure Limits) ever since EMA (European Medicines Agency) published its Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Regulatory Requirements for Cleaning Validation

 The FDA’s guide to cleaning inspections includes the following guidelines:  

  1. FDA expects firms to have written standard operating procedures (SOP) detailing the cleaning process used for various pieces of equipment.
  2. “FDA expects firms to have written procedures [Standard Operating Procedures (SOPs)] detailing the cleaning processes...”
  3. “FDA expects firms to have written general procedures on how cleaning processes will be validated.”
  4. These procedures will “address who is responsible for performing and approving the validation study, the acceptance criteria, and when revalidation will be required.”
  5. “FDA expects firms to conduct the validation studies in accordance with the protocols and to document the results of studies.”
  6. Besides ensuring chemical cleanliness, “the microbiological aspects of equipment cleaning should be considered. This consists largely of preventive measures…”
  7. “Determine the specificity and sensitivity of the analytical method used to detect residuals or contaminants.”
  8. “The firm should challenge the analytical method in combination with the sampling method(s) used to show that contaminants can be recovered from the equipment surface and at what level...”
  9. “Direct sampling (e.g., with swabs) is ‘most desirable,’ although rinse sampling may be satisfactory.”


Reduce cross contamination + Book Demo CTA

Want to learn more about Cleaning Validation, and how achieve your own compliance 4.0 ? The LeucineTech academy offers great training resources. Check out the following links: 
4 step guide to achieve Compliance 4.0




Posted on Jul 11, 2018 12:09:07 PM by Vivek Gera

Vivek Gera

Written by Vivek Gera

Vivek is the CEO of LeucineTech, a digital compliance platform that reduces the risk of drug FDA non-compliance (due to cross-contamination) by 80%.

Subscribe to Email Updates

Recent Posts

Posts by Topic